MP-08.21: A multicentre, randomised one year dose-finding study of degarelix, a gonadotrophin-releasing hormone (GnRH) receptor blocker, in prostate cancer patients

Urology ◽  
2007 ◽  
Vol 70 (3) ◽  
pp. 83-84
Author(s):  
M. Gittelman ◽  
P.J. Pommerville ◽  
B.E. Persson ◽  
T. Kold Olesen
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Gnrh Receptor ◽  
Dose Finding ◽  
Receptor Blocker ◽  
Releasing Hormone ◽  
Finding Study ◽  
Dose Finding Study ◽  
Gonadotrophin Releasing Hormone ◽  
One Year

Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer

2008 ◽  
Vol 54 (4) ◽  
pp. 805-815 ◽  
Author(s):  
Hendrik Van Poppel ◽  
Bertrand Tombal ◽  
Jean J. de la Rosette ◽  
Bo-Eric Persson ◽  
Jens-Kristian Jensen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Gnrh Receptor ◽  
Gonadotropin Releasing Hormone ◽  
Receptor Blocker ◽  
Phase 2 ◽  
Releasing Hormone ◽  
Finding Study

scholarly journals Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF

2001 ◽  
Vol 16 (3) ◽  
pp. 492-494 ◽  
Author(s):  
S.F. Yim ◽  
I.H. Lok ◽  
L.P. Cheung ◽  
C.M. Briton-Jones ◽  
T.T.Y. Chiu ◽  
...  
Keyword(s):  
Ovarian Stimulation ◽  
Dose Finding ◽  
Releasing Hormone ◽  
Finding Study ◽  
Dose Finding Study ◽  
Gonadotrophin Releasing Hormone ◽  
Long Acting

A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America

2008 ◽  
Vol 180 (5) ◽  
pp. 1986-1992 ◽  
Author(s):  
Marc Gittelman ◽  
Peter J. Pommerville ◽  
Bo-Eric Persson ◽  
Jens-Kristian Jensen ◽  
Tine Kold Olesen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
North America ◽  
Phase Ii ◽  
Dose Finding ◽  
Open Label ◽  
Randomized Phase Ii ◽  
Finding Study ◽  
Dose Finding Study
Sign in / Sign up

Export Citation Format

Share Document